Emma L James1, Eric K Parkinson. 1. Centre for Clinical and Diagnostic Oral Sciences, Institute of Dentistry, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Turner Street, London, UK.
Abstract
PURPOSE OF REVIEW: The aim of this study is to highlight some recent uses of serum metabolomics in human and animal studies. The main themes are the importance of understanding the underlying variation in human metabolism and the use of serum metabolomics in disease profiling. RECENT FINDINGS: Several studies have attempted to use serum metabolomics to develop noninvasive biomarkers of disease and/or track the consequences of nutritional and genetic interventions. Many advances have been made with common changes being identified in ageing, the menopause and cancer but several problems of interpretation have emerged from these studies. These include the small sample sizes in most human studies and the differences between human and rodent metabolomes. However, a metabolic screen of over 1000 'healthy' humans (the Humsermet project) has highlighted many variables that may be used to refine the interpretation and design of previous and future human studies alike, in addition to data mining. SUMMARY: Some common serum metabolome alterations have been identified but many inconsistencies remain. The construction of a human serum metabolome database should be informative in the design of future human and animal model studies.
PURPOSE OF REVIEW: The aim of this study is to highlight some recent uses of serum metabolomics in human and animal studies. The main themes are the importance of understanding the underlying variation in human metabolism and the use of serum metabolomics in disease profiling. RECENT FINDINGS: Several studies have attempted to use serum metabolomics to develop noninvasive biomarkers of disease and/or track the consequences of nutritional and genetic interventions. Many advances have been made with common changes being identified in ageing, the menopause and cancer but several problems of interpretation have emerged from these studies. These include the small sample sizes in most human studies and the differences between human and rodent metabolomes. However, a metabolic screen of over 1000 'healthy' humans (the Humsermet project) has highlighted many variables that may be used to refine the interpretation and design of previous and future human studies alike, in addition to data mining. SUMMARY: Some common serum metabolome alterations have been identified but many inconsistencies remain. The construction of a human serum metabolome database should be informative in the design of future human and animal model studies.
Authors: Jun Kou; Chunyang He; Lin Cui; Zhengping Zhang; Wei Wang; Li Tan; Da Liu; Wei Zheng; Wei Gu; Ning Xia Journal: Front Endocrinol (Lausanne) Date: 2022-04-19 Impact factor: 6.055
Authors: Sander M Houten; Jia Chen; Fiorella Belpoggi; Fabiana Manservisi; Alberto Sánchez-Guijo; Stefan A Wudy; Susan L Teitelbaum Journal: PLoS One Date: 2016-07-28 Impact factor: 3.240
Authors: Adam Zabek; Robert Paslawski; Urszula Paslawska; Wojciech Wojtowicz; Katarzyna Drozdz; Sergio Polakof; Marzena Podhorska; Piotr Dziegiel; Piotr Mlynarz; Andrzej Szuba Journal: PLoS One Date: 2017-10-09 Impact factor: 3.240